75 related articles for article (PubMed ID: 9551426)
1. P-glycoprotein functions and substrates: possible roles of MDR1 gene in the kidney.
Ernest S; Bello-Reuss E
Kidney Int Suppl; 1998 Apr; 65():S11-7. PubMed ID: 9551426
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
3. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells.
Ernest S; Bello-Reuss E
J Am Soc Nephrol; 1999 Nov; 10(11):2306-13. PubMed ID: 10541289
[TBL] [Abstract][Full Text] [Related]
4. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.
Romiti N; Tramonti G; Chieli E
Toxicol Appl Pharmacol; 2002 Sep; 183(2):83-91. PubMed ID: 12387747
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of the human MDR3 P-glycoprotein.
Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P
Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012
[TBL] [Abstract][Full Text] [Related]
7. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.
Pohl A; Lage H; Müller P; Pomorski T; Herrmann A
Biochem J; 2002 Jul; 365(Pt 1):259-68. PubMed ID: 12071854
[TBL] [Abstract][Full Text] [Related]
8. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
[TBL] [Abstract][Full Text] [Related]
9. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
[TBL] [Abstract][Full Text] [Related]
10. Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3.
Ernest S; Bello-Reuss E
Am J Physiol; 1996 Mar; 270(3 Pt 1):C910-9. PubMed ID: 8638674
[TBL] [Abstract][Full Text] [Related]
11. Several major antiepileptic drugs are substrates for human P-glycoprotein.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
[TBL] [Abstract][Full Text] [Related]
12. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
Zeng H; Lin ZP; Sartorelli AC
Biochem Pharmacol; 2004 Sep; 68(5):911-21. PubMed ID: 15294454
[TBL] [Abstract][Full Text] [Related]
13. Regulation of volume activated chloride channels by protein kinase C-mediated phosphorylation of P-glycoprotein.
Hardy SP; Valverde MA; Goodfellow HR; Higgins CF; Sepúlveda FV
Jpn J Physiol; 1994; 44 Suppl 2():S9-15. PubMed ID: 7752561
[TBL] [Abstract][Full Text] [Related]
14. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
15. Adenosine triphosphate-dependent transport of estradiol-17beta(beta-D-glucuronide) in membrane vesicles by MDR1 expressed in insect cells.
Huang L; Hoffman T; Vore M
Hepatology; 1998 Nov; 28(5):1371-7. PubMed ID: 9794924
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P-glycoprotein and multidrug resistance proteins in rat kidney and intestinal cell lines.
van de Water FM; Boleij JM; Peters JG; Russel FG; Masereeuw R
Eur J Pharm Sci; 2007 Jan; 30(1):36-44. PubMed ID: 17088052
[TBL] [Abstract][Full Text] [Related]
17. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
18. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
[TBL] [Abstract][Full Text] [Related]
19. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
20. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells.
Han LY; Ye MZ; Li YP; Wang BW; Wang Q; Zhao SH; Li HL
Chin Med J (Engl); 2008 May; 121(9):800-5. PubMed ID: 18701045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
